Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4013.SR · as of 2026-06-15
Financial statements
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $13.71B | $11.20B | $9.51B | $8.31B | $7.25B |
| Cost of Revenue | $9.50B | $7.46B | $6.29B | $5.56B | $4.92B |
| Gross Profit | $4.21B | $3.74B | $3.25B | $2.75B | $2.33B |
| Gross Margin %(computed) | 30.69% | 33.43% | 34.22% | 33.07% | 32.14% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.22B | $0.16B | $0.16B | $0.13B | $0.10B |
| Total Operating Expenses | $1.59B | $1.39B | $1.10B | $1.04B | $0.85B |
| Operating Income | $2.64B | $2.36B | $2.10B | $1.70B | $1.47B |
| Operating Margin %(computed) | 19.26% | 21.04% | 22.04% | 20.46% | 20.22% |
| Interest Income | $0.05B | $0.06B | $0.08B | $0.04B | $0.01B |
| Interest Expense | $0.36B | $0.18B | $0.08B | $0.06B | $0.05B |
| Income Before Tax | $2.52B | $2.41B | $2.17B | $1.80B | $1.50B |
| Income Tax Expense | $0.03B | $0.04B | $0.07B | $0.11B | $0.11B |
| Net Income | $2.40B | $2.32B | $2.05B | $1.65B | $1.38B |
| Net Margin %(computed) | 17.52% | 20.67% | 21.52% | 19.86% | 18.99% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.86 | $6.61 | $5.85 | $4.72 | $3.93 |
| Wtd Avg Shares | 0.35B | 0.35B | 0.35B | 0.35B | 0.35B |
| EBITDA | $3.31B | $2.99B | $2.55B | $2.15B | $1.86B |
| EBITDA Margin %(computed) | 24.15% | 26.72% | 26.85% | 25.84% | 25.62% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Dr. Sulaiman Al Habib Medical Services Group Company data
About Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) Income Statement
Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 4013.SR reported revenue of $13.71B, gross profit of $4.21B (gross margin 30.69%), and net income of $2.40B — a net profit margin of 17.52%.
Frequently asked questions
4013.SR · 4 questionsDr. Sulaiman Al Habib Medical Services Group Company (4013.SR) reported revenue of $13.71B for 2025, up 22.4% year-over-year.
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15